Immunotherapy targeting tumor neoantigenic peptides
US12152077B1 · kind B1 · utility
0Cited by
21References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 12, 2023 |
| Grant date | Nov 26, 2024 |
| Priority date | — |
| Expiry date | May 12, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/03
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a method for selecting a tumor neoantigenic peptide wherein said method comprises: The present disclosure also relates to tumor neoantigenic peptide obtained according to the present method, vaccine or immunogenic composition, antibodies and immune cells derived thereof and their use in therapy of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.